Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Imaging Chemically Modified Adenovirus for Targeting Tumors Expressing Integrin αvβ3 in Living Mice with Mutant Herpes Simplex Virus Type 1 Thymidine Kinase PET Reporter Gene

Zhengming Xiong, Zhen Cheng, Xianzhong Zhang, Manish Patel, Joseph C. Wu, Sanjiv S. Gambhir and Xiaoyuan Chen
Journal of Nuclear Medicine January 2006, 47 (1) 130-139;
Zhengming Xiong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhen Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianzhong Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manish Patel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph C. Wu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjiv S. Gambhir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoyuan Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The aim of this study was to change adenovirus tropism by chemical modification of the fiber knobs with PEGylated RGD peptide for targeting integrin αvβ3 that is uniquely or highly expressed in tumor cells and neovasculature of tumors of various origins. Methods: The first generation Ad (Ad) vector, which expresses the herpes simplex virus type 1 mutant thymidine kinase (HSV1-sr39tk) gene under the control of cytomegalovirus (CMV) promoter was conjugated with poly(ethylene glycol) (PEG) or RGD-PEG. The transduction efficiency of Ads (Adtk, PEG-Adtk, and RGD-PEG-Adtk) into different types of cells (293T, MCF7, MDA-MB-435, and U87MG) was analyzed and quantified by thymidine kinase (TK) assay using 8-3H-penciclovir (8-3H-PCV) as substrate. The in vivo infectivity of the Ad vectors after intravenous administration into integrin αvβ3–positive U87MG and MDA-MB-435 tumor-bearing athymic nude mice was measured by both noninvasive microPET using 9-[4-18F-fluoro-3-(hydroxymethyl)butyl]guanine (18F-FHBG) as a reporter probe and ex vivo TK assay of the tumor and tissue homogenates. Results: PEGylation completely abrogated coxsackievirus and adenovirus receptor (CAR)–knob interaction and the infectivity of PEG-Adtk is significantly lower than that of unmodified Adtk in CAR-positive cells. RGD-PEG–modified virus (RGD-PEG-Adtk) had significantly higher infectivity than PEG-Adtk and the extent of increase is related to both CAR and integrin αvβ3 expression levels. 18F-FHBG had minimal nonspecific uptake in the liver and tumors that are void of sr39tk. Mice preinjected intravenously with unmodified Adtk resulted in high hepatic uptake and moderate tumor accumulation of the tracer. In contrast, RGD-PEG-Adtk administration resulted in significantly lower liver uptake without compromising the tumor accumulation of 18F-FHBG. Expression of TK in the liver and tumor homogenates corroborated with the magnitude of 18F-FHBG uptake quantified by noninvasive microPET. Analysis of liver and tumor tissue integrin level confirmed that RGD–integrin interaction is responsible for the enhanced tumor infectivity of RGD-PEG-Adtk. Conclusion: The results of this study suggest that RGD-PEG conjugation is an effective way to modify Ad vector tropism for improved systemic gene delivery. Noninvasive PET and 18F-FHBG are able to monitor in vivo transfectivity of both Adtk and RGD-PEG-Adtk vectors in the liver and tumors after intravenous injection.

  • adenovirus
  • reporter gene
  • gene therapy
  • integrin
  • RGD
  • PET
View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (1)
Journal of Nuclear Medicine
Vol. 47, Issue 1
January 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Imaging Chemically Modified Adenovirus for Targeting Tumors Expressing Integrin αvβ3 in Living Mice with Mutant Herpes Simplex Virus Type 1 Thymidine Kinase PET Reporter Gene
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Imaging Chemically Modified Adenovirus for Targeting Tumors Expressing Integrin αvβ3 in Living Mice with Mutant Herpes Simplex Virus Type 1 Thymidine Kinase PET Reporter Gene
Zhengming Xiong, Zhen Cheng, Xianzhong Zhang, Manish Patel, Joseph C. Wu, Sanjiv S. Gambhir, Xiaoyuan Chen
Journal of Nuclear Medicine Jan 2006, 47 (1) 130-139;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Imaging Chemically Modified Adenovirus for Targeting Tumors Expressing Integrin αvβ3 in Living Mice with Mutant Herpes Simplex Virus Type 1 Thymidine Kinase PET Reporter Gene
Zhengming Xiong, Zhen Cheng, Xianzhong Zhang, Manish Patel, Joseph C. Wu, Sanjiv S. Gambhir, Xiaoyuan Chen
Journal of Nuclear Medicine Jan 2006, 47 (1) 130-139;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • Assessment of Quantitative Perfusion Parameters by Dynamic Contrast-Enhanced Sonography Using a Deconvolution Method: An In Vitro and In Vivo Study
  • Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments
  • Timing of Ganciclovir Administration in Glioma Gene Therapy Using HSVtk Gene-transduced Mesenchymal Stem Cells
  • Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor
  • PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)-Conjugated Radiolabeled Iron Oxide Nanoparticles
  • Multimodality Molecular Imaging of Tumor Angiogenesis
  • Multimodality Molecular Imaging of Glioblastoma Growth Inhibition with Vasculature-Targeting Fusion Toxin VEGF121/rGel
  • PET of Vascular Endothelial Growth Factor Receptor Expression
  • Google Scholar

More in this TOC Section

  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire